Understanding endometriosis
Endometriosis is one of the most common gynecological disorders, affecting 5.5 million women in North America alone. Endometriosis occurs when the endometrial tissue that grows inside the uterus, grows outside the uterus—on the ovaries, fallopian tubes and other areas in the pelvis. The breakdown and bleeding of this tissue each month can cause scar tissue called lesions. Although there is no cure for endometriosis, there are several treatment options, such as surgery, medications and hormone therapy. Talk to your doctor about which options are available to you.

LUPRON DEPOT® (leuprolide acetate for depot suspension) 3.75 mg and – 3 Month 11.25 mg is used for the management of endometriosis, including pain relief and reduction of endometriotic lesions. LUPRON DEPOT with daily norethindrone acetate 5 mg is also indicated for initial management of endometriosis and for management of recurrence of symptoms. The recommended initial treatment is no more than 6 months. Repeat treatment for endometriosis should be limited to 6 months.
You should not receive LUPRON DEPOT if you are or may become pregnant, are breast-feeding or have undiagnosed vaginal bleeding. Increased endometriosis symptoms (i.e. pelvic pain or pressure and/or pain during intercourse) may occur for 1 or 2 weeks after starting this drug. Development or worsening of depression has occurred. Condoms, a diaphragm with contraceptive jelly, or an IUD is required to prevent pregnancy. Thinning of the bones, which may not be completely reversible, can occur during treatment with this drug. Norethindrone acetate used as add-back therapy with LUPRON DEPOT has additional serious risks and considerations.
Please see additional Important Safety Information you should know about Lupron Depot and discuss it with your doctor.
Please see the full Prescribing Information for Lupron Depot and discuss it with your doctor.